HOME
ABOUT US
ADVERTISE
SUBSCRIBE
SITE MAP
HELP
CONTACT
WORK FOR US
Friday
10 September 2010
Make BTN my HomePage
INDUSTRIAL BIOTECH STORIES
[ 93 Results - Showing Results 1 to 30 ]
ASIC eyeballs bottom line
(Thursday, 12 August 2010)
FOLLOWING the transfer of market supervision from the Australian Securities Exchange to the Australian Securities and Investments Commission earlier this month, ASX queries are rolling in, with Giaconda, AnaeCo and Benitec being the latest to respond to questions about their financials.
Full Story...
Market Pulse: Up for some
(Monday, 2 August 2010)
AS companies debuted quarterly results, therapeutics developer Alchemia and medical devices company ImpediMed both had cracker weeks, with gains of close to 30%.
Full Story...
Bio Briefs: Alchemia, Benitec, Stirling and more
(Thursday, 15 July 2010)
ALCHEMIA has more positive news for the market after last week’s rollercoaster, revealing it has entered into a marketing agreement with its partner Dr Reddy’s for its generic anticoagulant fondaparinux sodium in all markets outside of North America.
Full Story...
Bio Briefs: SA + the feds, Cortical and more
(Friday, 9 July 2010)
THE South Australia and federal governments have opened a new $7 million funding round for their South Australia Innovation and Investment Fund to create 300 more jobs in the state.
Full Story...
Bio People: MediVac, ACPFG, Benitec and more
(Thursday, 3 June 2010)
HEALTHLINX managing director Nick Gatsios has resigned from his non-executive post on the board of MediVac, a hospital waste management and infection control provider.
Full Story...
WA upgrades hospital technology
(Thursday, 20 May 2010)
WESTERN Australia’s public hospitals will get more than $120 million of new clinical and diagnostic medical equipment over the coming three years as the state seeks to improve its standard of care.
Full Story...
Bio People: BioDiem, AAS, ASIC and more
(Monday, 10 May 2010)
BIODIEM chief executive
Julie Phillips
has joined the company’s board as an executive director.
Full Story...
Fluorotechnics at risk
(Monday, 3 May 2010)
AS devices company Fluorotechnics (Gelcompany) launched a $A2.2 million capital raising, it has warned there is a risk it may not be able to continue.
Full Story...
WA seeks Innovator of the Year
(Tuesday, 20 April 2010)
AFTER a one-year hiatus, the Western Australia government has re-launched its inventor awards and is calling for applications from the state’s innovative start-ups and growing companies, offering prizes and assistance to those on the path to commercialisation.
Full Story...
CA delivers $4.9M first funding to biotechs
(Friday, 16 April 2010)
FUNDING initiative Commercialisation Australia will serve up $9.7 million for innovation in its first round of funding with more than half going to biotechnology companies.
Full Story...
Bio Briefs: Agenix, MediVac, Imugene and more
(Thursday, 8 April 2010)
A SUBSIDIARY of suspended company Agenix has continued to pull back cash from a failed 2007 transaction in China, collecting 9.2 million yuan ($A1.5 million) in February and March.
Full Story...
Capital Briefs: BioDiem, Viralytics, Acuvax, Cardia
(Thursday, 25 March 2010)
BIOPHARMACEUTICAL developer BioDiem has debuted its first shareholder placement since 2006 with a $7.5 million pro rata rights issue.
Full Story...
OneVentures captures $20M, commits $20M
(Tuesday, 23 March 2010)
SYDNEY-based venture capital firm OneVentures, which is focused on emerging life science, clean technology and new media companies, has been named as the final fund to receive $A20 million in support from tranche 2, round 3 of the federal government’s Innovation Investment Fund.
Full Story...
Capital Briefs: YM BioSciences, Cytopia, Sun BioMedical, AnaeCo, PharmaNet, BPH Corporate
(Thursday, 11 March 2010)
YM BioSciences, the Canadian life sciences product developer that swallowed up Cytopia, has closed an offering to investors after raising close to $US17.5 million ($A19.1 million) from sophisticated investors.
Full Story...
Bio Briefs: Unilife, Cardia Bioplastics, SafetyMed, pSivida, Aquacarotene
(Tuesday, 9 March 2010)
THE Australian Taxation Office has granted tax relief to investors in recent North America emigrant Unilife Corporation.
Full Story...
Accountants kill biotech innovation: UQ
(Thursday, 4 March 2010)
A TEAM of innovation experts has named the number one enemy of biotech innovation – accountants and their pesky love of costing and evaluating projects up-front.
Full Story...
Bio People: ASDM, Virax and Progen
(Tuesday, 2 March 2010)
FORMER Optus start-up chief executive officer and seasoned strategy and project manager John O’Meara will join the Advanced Surgical Design and Manufacture board as a non-executive director.
Full Story...
Nanotechnology gains in popularity
(Tuesday, 2 March 2010)
NANOTECHNOLOGY is becoming a more recognised term among Australians, with most people forming positive views about the science, according to a recent survey.
Full Story...
CSIRO travels Metabolic paved road
(Tuesday, 23 February 2010)
THE CSIRO has offloaded its stake in biomaterials spin-off PolyNovo for a 4.7% share of its parent company Calzada, which formerly traded as Metabolic.
Full Story...
Bio People: Calzada, Metabolic Pharmaceuticals, PolyNovo
(Tuesday, 23 February 2010)
THE
Calzada
group has appointed Metabolic Pharmaceuticals founder David Kenley as the new chief executive officer of subsidiary Metabolic – in one of a number of senior management changes at the group.
Full Story...
Bio Briefs: ITL, Cardia, BioProspect
(Tuesday, 23 February 2010)
ITL Corporation has signed a three-year deal with American Red Cross, extending a supply contract for ancillary devices used for blood collection.
Full Story...
Bio People: CathRx, NuSep, BioInquire *UPDATED*
(Thursday, 18 February 2010)
FORMER Boston Scientific Corporation executive vice president and president international Jeffrey Goodman has joined cardiac catheter manufacturer CathRx as its chief executive officer and managing director.
Full Story...
Capital Briefs: AnaeCo, Genesis Research and Development
(Thursday, 18 February 2010)
ALTERNATIVE waste technology facility provider AnaeCo has continued with its fundraising drive despite being queried by the Australian Securities Exchange last Friday about its cash reserves.
Full Story...
NuSep snaps up BioInquire
(Thursday, 18 February 2010)
MANUFACTURER NuSep has signed a binding sales agreement for the $US1.5 million ($A1.7 million) purchase of North American software developer BioInquire.
Full Story...
Stability, funding for PolyNovo
(Tuesday, 12 January 2010)
CALZADA (formerly Metabolic) has pushed back plans to spin out PolyNovo, making an offer to the company’s other major shareholders for their holdings and committing to fund the biomaterial company’s development for at least the next 12 to 24 months.
Full Story...
BioProspect signs termite-killing deal
(Thursday, 24 December 2009)
US pest control company Ensystex Corporation has taken up its option to develop BioProspect’s Termilone termite product, agreeing to pay for field trials of the product as a soil-applied termite killer.
Full Story...
Invetech delivers first production ‘tissue printer’ *UPDATED*
(Thursday, 3 December 2009)
MELBOURNE contract manufacturer Invetech has delivered the world’s “first production model 3D bio-printer” to US client Organovo, based on prototypes supplied by the US technology developer.
Full Story...
More life science grants from Climate Ready scheme
(Tuesday, 10 November 2009)
FOUR life science companies have taken out just under $1 million between them from the latest round of federal government Climate Ready grants, which totalled $20.6 million and were handed out to a range of companies this week.
Full Story...
AquaSens takes first steps towards commercialisation
(Thursday, 17 September 2009)
UNLISTED Adelaide company CleanFutures AquaSens has taken the first steps towards commercialising its nanotechnology-based biosensor technology, receiving a $50,000 grant from Bio Innovation SA to finalise the design of its sensors and conduct the first round of customer trials of the device.
Full Story...
OPINION: What price an IPO?
(Tuesday, 1 September 2009)
THE Australian life science sector hasn’t seen a true initial public offering since Fluorotechnics listed on the Australian Securities Exchange in October last year. Is the time ripe for another?
BTN
seeks the views of the analysts who watch the life science sector.
Full Story...
Prev
Next
Company Search
Story Search
Advanced Search
UPCOMING
EVENTS
ABIC 2010 - Bridging Biology and Business
14th International Biotechnology Symposium & Exhibition 2010
BIO India Partnering Conference 2010
OZBIO2010
2010 Livestock Biotech Summit
BioPartnering Europe
View all events
LATEST NEWS
Novogen offers treats to Marshall
Research frameworks must change
Agenix shines like $5M diamonds
Phylogica warns of $106M uncertainty
Bio People: ARTrinsic, iNova
UBI seeks CEO
BioDiem orphaned by FDA
BioDiem fights bird flu with CDC-Merck
Broadvector prepares $24.5M bang
Bio People: Australia, Research Australia, KarmelSonix and more *UPDATED*
Disclaimer
|
© Copyright Aspermont Ltd
|
Privacy Policy
|
Terms and Conditions
